Unprecedented outbreaks of infections and rising awareness of people and policy makers towards the vital use of diagnostic tools are driving the infectious disease diagnostics market. The stringent government regulations constitute barriers for new competitors and control price rise, posing a challenge to the growth of the market.
The reports, books, and subscriptions listed under Research and Markets’ Infectious Disease Testing examine the latest developments across a range of ailments
such as HIV/AIDS, HPV and other sexually transmitted diseases, hepatitis, herpes, tuberculosis, and hospital-associated infections. Worth several billion dollars in the US alone, this is a challenging, evolving and highly investible sector.